Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Mod Pathol ; 35(9): 1175-1180, 2022 09.
Artículo en Inglés | MEDLINE | ID: covidwho-2016645

RESUMEN

Current public health initiatives to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) global pandemic focus on expanding vaccination efforts to include vulnerable populations such as pregnant people. Vaccines using messenger ribonucleic acid (mRNA) technology rely on translation by immune cells, primarily at the injection site. Hesitancy remains among the general population regarding the safety of mRNA vaccines during gestation, and it remains unknown whether the SARS-CoV-2 Spike protein (the product of mRNA vaccines available) accumulates in the placenta after vaccination. Objective: To determine whether Spike protein translation and accumulation occurs in placental tissue in the context of recent mRNA SARC-CoV-2 vaccination during pregnancy. We identified 48 patients receiving one or two doses of mRNA SARS-CoV-2 vaccine during gestation and used immunohistochemistry against SARS-CoV-2 Spike protein in formalin-fixed, paraffin-embedded placental tissue. One placenta, positive for SARS-CoV-2 RNA by in situ hybridization (ISH) was used as positive control. Seven term placentas collected prior to the emergence of SARS-CoV-2 served as negative controls. Eighty one percent of patients in the study group underwent third-trimester delivery; remaining had a first-trimester spontaneous abortion or elective second-trimester termination. Patients received two (52%) or one (48%) vaccine doses during pregnancy, with a median interval between latest dose and delivery of 13 days (range 2-79 days). Most (63%) cases had their latest dose within 15 days prior to delivery. All the placentas in the study and negative control groups were negative for SARS-CoV-2 immunohistochemistry. Six study cases with short vaccine-delivery intervals (2-7 days) were subjected to SARS-CoV-2 ISH and were negative. Our findings suggest that mRNA vaccines do not reach significant concentrations in the placenta given the absence of definitive SARS-CoV-2 Spike protein accumulation in placental tissue. This observation provides evidence supporting the safety of mRNA vaccines to the placental-fetal unit.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Placenta , Complicaciones Infecciosas del Embarazo , Glicoproteína de la Espiga del Coronavirus , COVID-19/prevención & control , Vacunas contra la COVID-19/administración & dosificación , Femenino , Humanos , Placenta/virología , Embarazo , Complicaciones Infecciosas del Embarazo/prevención & control , Complicaciones Infecciosas del Embarazo/virología , SARS-CoV-2 , Glicoproteína de la Espiga del Coronavirus/análisis , Vacunación
2.
Placenta ; 109: 72-74, 2021 06.
Artículo en Inglés | MEDLINE | ID: covidwho-1386464

RESUMEN

Whether early SARS-CoV-2 definitively increases the risk of stillbirth is unknown, though studies have suggested possible trends of stillbirth increase during the pandemic. This study of third trimester stillbirth does not identify an increase in rates during the first wave of the pandemic period, however investigation of the placental pathology demonstrates trends towards more vascular placental abnormalities.


Asunto(s)
COVID-19/epidemiología , Enfermedades Placentarias/epidemiología , Complicaciones Infecciosas del Embarazo/epidemiología , Tercer Trimestre del Embarazo , Mortinato/epidemiología , Adulto , COVID-19/complicaciones , COVID-19/mortalidad , Causas de Muerte , Femenino , Muerte Fetal/etiología , Humanos , Recién Nacido , Transmisión Vertical de Enfermedad Infecciosa/estadística & datos numéricos , Pandemias , Placenta/patología , Enfermedades Placentarias/etiología , Enfermedades Placentarias/patología , Enfermedades Placentarias/virología , Embarazo , Complicaciones Infecciosas del Embarazo/mortalidad , SARS-CoV-2/fisiología , Estados Unidos/epidemiología , Adulto Joven
3.
Mod Pathol ; 33(11): 2092-2103, 2020 11.
Artículo en Inglés | MEDLINE | ID: covidwho-693331

RESUMEN

Congenital infection of SARS-CoV-2 appears to be exceptionally rare despite many cases of COVID-19 during pregnancy. Robust proof of placental infection requires demonstration of viral localization within placental tissue. Only two of the few cases of possible vertical transmission have demonstrated placental infection. None have shown placental expression of the ACE2 or TMPRSS2 protein, both required for viral infection. We examined 19 COVID-19 exposed placentas for histopathologic findings, and for expression of ACE2, and TMPRSS2 by immunohistochemistry. Direct placental SARS-CoV-2 expression was studied by two methods-nucleocapsid protein expression by immunohistochemistry, and RNA expression by in situ hybridization. ACE2 membranous expression in the syncytiotrophoblast (ST) of the chorionic villi is predominantly in a polarized pattern with expression highest on the stromal side of the ST. In addition, cytotrophoblast and extravillous trophoblast express ACE2. No ACE2 expression was detected in villous stroma, Hofbauer cells, or endothelial cells. TMPRSS2 expression was only present weakly in the villous endothelium and rarely in the ST. In 2 of 19 cases, SARS-CoV-2 RNA was present in the placenta focally in the ST and cytotrophoblast. There was no characteristic histopathology present in our cases including the two placental infections. We found that the placenta is capable of being infected but that this event is rare. We propose one explanation could be the polarized expression of ACE2 away from the maternal blood and pronounced paucity of TMPRSS2 expression in trophoblast.


Asunto(s)
Infecciones por Coronavirus/virología , Placenta/patología , Placenta/virología , Neumonía Viral/virología , Complicaciones Infecciosas del Embarazo/virología , Adulto , Enzima Convertidora de Angiotensina 2 , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/patología , Femenino , Humanos , Pandemias , Peptidil-Dipeptidasa A/biosíntesis , Placenta/metabolismo , Neumonía Viral/patología , Embarazo , Complicaciones Infecciosas del Embarazo/metabolismo , Complicaciones Infecciosas del Embarazo/patología , ARN Viral/análisis , SARS-CoV-2 , Serina Endopeptidasas/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA